ArticleThe American journal of cardiology2019
The Evolving Management of Aortic Valve Disease: 5-Year Trends in SAVR, TAVR, and Medical Therapy.
Article in The American journal of cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 52 citations in OpenAlex.
- Transapical epicardial temporary pacemaker lead implantation in patients with transapical TAVI.Open heart · 2026Article
- Mortality and morbidity benefits of surgical versus transcatheter aortic valve replacement in patients ≤60 years: Findings from a national cohort.JTCVS open · 2026Article
- Impact of pre-procedural requirements on time to aortic valve replacement: Transcatheter AVR vs surgical AVR.American heart journal plus : cardiology research and practice · 2026Article
- Transcatheter Versus Surgical Aortic Valve Replacement in Women of Childbearing Age in the United States.Structural heart : the journal of the Heart Team · 2025Article
- Sex-Associated Disparities in Surgical and Percutaneous Management of Aortic Stenosis With Severe Features: Retrospective Analysis From the National Readmission Database.Journal of the American Heart Association · 2025Article
- In-Hospital Outcomes and 30-Day Readmission Rate After Transcatheter and Surgical Aortic Valve Replacement in Liver Cirrhosis: A Contemporary Propensity-Matched Analysis.Structural heart : the journal of the Heart Team · 2024Article
- The Cost of Waiting for a Transcatheter Aortic Valve Replacement in Medicare Beneficiaries With Severe Aortic Stenosis.Structural heart : the journal of the Heart Team · 2024Article
- Breaking Down Barriers to Transcatheter Aortic Valve Replacement.Journal of the Society for Cardiovascular Angiography & Interventions · 2024Article
- Aortic Stenosis Risk in Rheumatoid Arthritis.JAMA internal medicine · 2023Article
- Assessment of valve implantation in the descending aorta as an alternative for aortic regurgitation patients not treatable with conventional procedures.Biomechanics and modeling in mechanobiology · 2023Article
- Racial and ethnic disparities in diagnosis, management and outcomes of aortic stenosis in the Medicare population.PloS one · 2023Article
- Trends in Medicare Payments for Beneficiaries With Aortic Stenosis.Journal of the American Heart Association · 2022Article
- Utilization and outcomes of aortic valve replacements (from the United States readmissions database).American heart journal plus : cardiology research and practice · 2022Article
- A novel endovascular treatment for transcatheter aortic valve embolization.Journal of vascular surgery cases and innovative techniques · 2021Article
- Prognostic Value of the Three-Dimensional Right Ventricular Ejection Fraction in Patients With Asymptomatic Aortic Stenosis.Frontiers in cardiovascular medicine · 2021Article
- Supraglottic Airway Use for Transfemoral-Transcatheter Aortic Valve Replacement.Journal of cardiothoracic and vascular anesthesia · 2020Article
- Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10-Year Trends and New Challenges.Journal of the American Heart Association · 2020Article
- TAVR: A Review of Current Practices and Considerations in Low-Risk Patients.Journal of interventional cardiology · 2020Review
- Transcatheter Aortic Valve Implantation Current Indications and Future Directions.Frontiers in cardiovascular medicine · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 7 institutions in 1 country.
Funding
Abstract
Aortic stenosis (AS) and regurgitation (AR) may be treated with surgical aortic valve replacement (SAVR), transcatheter AVR (TAVR), or medical therapy (MT). Data are lacking regarding the usage of SAVR, TAVR, and MT for patients hospitalized with aortic valve disease and the characteristics of the patients and hospitals associated with each therapy. From the Nationwide Readmissions Database, we determined utilization trends for SAVR, TAVR, and MT in patients with aortic valve disease admitted from 2012 to 2016 for valve replacement, heart failure, unstable angina, non-ST-elevation myocardial infarction, or syncope. We also performed multinomial logistic regressions to investigate associations between patient and hospital characteristics and treatment. Among 366,909 patients hospitalized for aortic valve disease, there was a 48.1% annual increase from 2012 through 2016. Overall, 19.9%, 6.7%, and 73.4% of patients received SAVR, TAVR, and MT, respectively. SAVR decreased from 21.9% in 2012 to 18.5% in 2016, whereas TAVR increased from 2.6% to 12.5%, and MT decreased from 75.5% to 69.0%. Older age, female sex, greater severity of illness, more admission diagnoses, not-for-profit hospitals, large hospitals, and urban teaching hospitals were associated with greater use of TAVR. In multivariable analysis, likelihood of TAVR relative to SAVR increased 4.57-fold (95% confidence interval 4.21 to 4.97). TAVR has increased at the expense of both SAVR and MT, a novel finding. However, this increase in TAVR was distributed inequitably, with certain patients more likely to receive TAVR certain hospitals more likely to provide TAVR. With the expected expansion of indications, inequitable access to TAVR must be addressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.